Records containing: Malignant Gliomas

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-12-04
Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
CLINICAL_TRIALS study record update · 2024-07-03
ClinicalTrials.gov study NCT01657734
CLINICAL_TRIALS study record update · 2023-01-31
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
CLINICAL_TRIALS study record update · 2022-05-06
Understanding the Mechanisms of ALA-induced Fluorescence in Malignant Gliomas - Exploring the Biological Basis of Tumoral Heterogeneity.
CLINICAL_TRIALS study record update · 2022-02-03
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2021-07-21
A Phase 2 Study of Valproic Acid and Radiation, Followed by Maintenance Valproic Acid and Bevacizumab in Children With Newly Diagnosed High-grade Gliomas or Brainstem Gliomas
CLINICAL_TRIALS study record update · 2020-10-19
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
CLINICAL_TRIALS study record update · 2019-12-05
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
CLINICAL_TRIALS study record update · 2019-02-25
A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients With Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
CLINICAL_TRIALS study record update · 2018-11-13
Phase I Trial of Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
CLINICAL_TRIALS study record update · 2014-09-15
Feasibility Study of Magnetic Resonance Spectroscopy and Dynamic Enhanced Cat Scan Imaging in Glioblastomas Treated With and Without Avastin
CLINICAL_TRIALS study record update · 2013-06-26
A Phase I Dose Escalation Study of Vandetanib (ZACTIMA, ZD6474) With Hypofractionated Stereotactic Radiotherapy in Patients With Recurrent Malignant Gliomas
CLINICAL_TRIALS study record update · 2013-06-25
A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas
CLINICAL_TRIALS study record update · 2013-04-10
A Phase 1 Dose-Escalation Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Subjects With Malignant Gliomas
CLINICAL_TRIALS study record update · 2012-08-22
Efficacy and Safety of Salvage Treatment With Dose-dense TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas: a Multicentre,Prospective Clinical Study
CLINICAL_TRIALS study record update · 2012-06-08
A Phase II Trial of Bevacizumab for Patients With Recurrent High-Grade Gliomas
CLINICAL_TRIALS study record update · 2010-03-10
Phase II Study of Lenalidomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme.
CLINICAL_TRIALS study record update · 2008-12-11
A Phase II Trial With Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas and Progression After Radiation Therapy and Temozolamide
CLINICAL_TRIALS study record update · 2007-01-04
Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas